Many mothers mistakenly believe that the risk associated with Celexa and other citalopram treatments exists only during pregnancy. While Celexa’s pregnancy-related risks are very real, particularly during the final trimester, the reality is that women who take Celexa while they are nursing put their children at risk of ingesting citalopram through breast milk. The side effects of neonatal exposure can be significant and may include excessive somnolence, decreased feeding, and weight loss, among others.
Fears Nachawati is committed to protecting mothers, infants, and families against dangerous drugs, such as Celexa and other selective serotonin reuptake inhibitors (SSRIs), their insufficient warnings, and tragic effects. If your child was born with SSRI-related birth defects, you should give us a call. The consultation is free and the information we can provide you could dramatically improve your family’s life. Contact us today by calling 1.866.545.8364 or emailing mn@fnlawfirm.com. We can help.